GLP-1 Medications for Weight Loss & Metabolic Support
Oral (Pills) and Injectable Options Available
CareBareRX offers both oral and injectable GLP-1 medications — including Semaglutide and Tirzepatide — to support sustainable weight management, appetite regulation, and improved metabolic health. Whether you prefer a once-daily pill or a weekly injection, your provider will help determine the best fit based on your health needs, comfort, and treatment goals.
Oral GLP-1 Options
Used alongside healthy lifestyle changes, oral GLP-1s can support:
Sustained weight management
Blood sugar control (for type 2 diabetes)
Appetite regulation and metabolic balance
Semaglutide (Rybelsus®) + Tirzepatide (Oral Form)
For patients looking for GLP-1 benefits without injections, CareBareRX offers oral options — including Semaglutide in pill form (Rybelsus®) and emerging oral Tirzepatide formulations that may be prescribed based on your eligibility.
These oral medications are taken by mouth and absorbed through the digestive system. They’re ideal for patients who prefer a needle-free approach and are committed to daily use.
Injectable GLP-1 Options
Many patients report feeling:
fewer cravings
smaller portions
and better energy with weekly injectable support.
Semaglutide (Compounded) + Tirzepatide (Compounded)
Once-Weekly Injections for Powerful Metabolic Results
CareBareRX also offers injectable versions of Semaglutide and Tirzepatide, typically administered once weekly. These formulations deliver medication directly into the bloodstream through a small subcutaneous injection (under the skin), offering a convenient and effective way to manage appetite, weight, and insulin sensitivity.
Semaglutide (Oral – Rybelsus®):
The first oral GLP-1 receptor agonist approved by the FDA. Taken once daily, it offers the same class of support as injectable Semaglutide, but in a tablet form.
Tirzepatide (Oral Form):
A dual-acting GLP-1 + GIP receptor agonist. While the FDA-approved version is injectable, oral options may be available through compounded or research-based prescribing, depending on provider discretion.
Semaglutide (Injectable):
A once-weekly GLP-1 injection that helps support significant and sustained weight loss, reduce appetite, and improve metabolic markers.
Tirzepatide (Injectable):
Combines GLP-1 and GIP receptor activation for powerful, once-weekly appetite and blood sugar support. Shown to result in higher average weight loss compared to GLP-1 alone.
How It Works
Three Simple Steps to Feeling Like Your Best Self
Quick Online Evaluation
Submit your intake form securely online.
Personalized Plan
Our licensed providers review your health history to determine the safest, most effective option.
Delivery
If eligible, prescriptions are delivered discreetly to your door.
HIPAA-Compliant
〰️
No Insurance Needed
〰️
Science-Backed Treatments
〰️
HIPAA-Compliant 〰️ No Insurance Needed 〰️ Science-Backed Treatments 〰️
Private & Effective.
At CareBareRX, we believe affirming, science-backed care should be accessible, stigma-free, and empowering — no matter your delivery preference.
Medications may include:
Semaglutide (Rybelsus®)
Tirzepatide (Oral form)
Disclaimer: Prescription products require consultation with a licensed provider. All medication information provided on this page is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Please review the full safety information for GLP-1’s before use, including potential side effects, contraindications, and warnings. Always take medications exactly as prescribed by your healthcare provider.